Search
Selected: C

Conus californicus neurotoxins

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Conversion of apoptotic proteins

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Convertible microemulsion formulations

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Convertible microemulsion formulations

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Convertible microemulsion formulations

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Convertible microemulsion formulations

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Cooperative combinations of ligands contained within a matrix

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Cop 1 for treatment of inflammatory bowel diseases

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Copolymer 1 related polypeptides for use as molecular weight...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Copolymer-1 improvements in compositions of copolymers

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Copolymer-1 improvements in compositions of copolymers

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Copolymer-1 improvements in compositions of copolymers

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Copolymer-1 improvements in compositions of copolymers

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Copolymer-1 improvements on compositions of copolymers

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Corneal therapeutic agent

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Corpuscles of stannius protein, stanniocalcin

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Corticotropin release inhibiting factor and methods of using sam

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Corticotropin releasing factor 2 receptor agonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Corticotropin releasing factor 2 receptor agonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Corticotropin releasing factor 2 receptor agonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0
  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.